Objectives: Topical minoxidil and oral finasteride are the gold standard therapies for AGA and the only two drugs currently that have US Food and Drug Administration (FDA)-approved indications for the treatment of hair loss.

Introduction: Emerging treatment modalities for hair loss include injectable platelet rich plasma (PRP), low-level laser therapy (LLLT), microneedling and oral nutraceuticals. Several peer reviewed studies have demonstrated the safety and efficacy of these methodologies although no standardized protocols exist to date. A new trend of combining therapies in order to achieve maximum

Materials / method: Peer-reviewed studies were analyzed for new treatment modalities showing a safe efficacious profile for treating hair loss.

Results: Several new treatment therapies including lasers, PRP and topical/oral cosmeceuticals are showing promising results in treating hair loss in both men and women. Combination approaches using PRP with fractional lasers and/or microneedling can increase the efficacy of these new treatment modalities.

Conclusion: New generation of treatment modalities show promise as therapeutic options for hair loss.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Cutera venus

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability